In Light of Upcoming Fosamax Litigation, Parker Waichman LLP Discusses Risk of Femur Fractures Associated with … Merck is set to face Fosamax (alendronate) lawsuits later this month in New Jersey, according to Parker Waichman LLP. Fosamax, which is used to fight bone loss from conditions such as osteoporosis, has sparked a number of lawsuits after being associated with an increased risk of femur fractures. (PRWeb March 05, 2013) Read the full story at http://www.prweb.com/releases/fosamax_lawsuits/032013 ... [News Source]